A new HIV drug, lenacapavir, appears highly effective against strains circulating in Uganda, according to a study led by Weill Cornell Medicine. Researchers found that only 1.6% of 546 Ugandan patients had mutations linked to lenacapavir resistance,

Life for Mike Elvis Tusubira, a motorcycle taxi rider with HIV in Uganda, has been turned upside down since US President Donald Trump halted foreign aid last month. Not only does the 35-year-old fear for his own survival as he takes life-saving anti-retroviral (ARV) drugs - but he says he will have to split up from his wife as they can no longer have safe sex.

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.

A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda. The study,

The Trump administration's stop-work order is affecting the HIV response in Uganda, along with malaria and TB programs globally. Plus, a look inside the infamous "Tunnel 12," the source of Rwanda’s Marburg outbreak.

The US aid freeze has critically impacted thousands in Uganda, especially those with HIV, by halting the supply of crucial ARV drugs and preventive medications. This disruption has forced clinics to shut down,

Waivers were subsequently issued for humanitarian projects, but by that time the HIV programme Mr Tusubira was part of - run out of Marpi Clinic in the north of the capital, Kampala - had closed.

The latest report from the Uganda AIDS Commission has indicated that Rukungiri at 8.3% has the highest HIV prevalence rate in Kigezi sub region.

Simon Peter Singo, medical director at Mengo Hospital, a teaching hospital in Kampala, warns of an impending health crisis, particularly in HIV/AIDS treatment and prevention. “The donor money has been used to pay salaries of the HIV staff team [at Mengo ...

Vincent Bagambe, Director of Planning and Strategic Information at UAC, warned that the withdrawal of U.S. funding could reverse the significant progress Uganda has made in combating HIV/AIDS.

The unstaffed reception area at the Kampala offices of Uganda Young Positives (UYP) on February 12. UYP is a nongovernmental organization that aims to improve the quality of life for young people living with HIV/AIDS and reduce infection rates through ...